Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

1.

[Gefitinib treatment in lung cancer - Rebiopsy, retreatment, remission].

Moldvay J, Pápay J, Kovalszky I, Balázs G, Puskás R, Losonczy G.

Magy Onkol. 2014 Jul;58(2):133-7. Epub 2014 Mar 5. Hungarian.

PMID:
25010762
[PubMed - in process]
Free Article
2.

An automated causality assessment algorithm to detect drug-induced liver injury in electronic medical record data.

Cheetham TC, Lee J, Hunt CM, Niu F, Reisinger S, Murray R, Powell G, Papay J.

Pharmacoepidemiol Drug Saf. 2014 Jun;23(6):601-8. doi: 10.1002/pds.3531. Epub 2013 Oct 21.

PMID:
24920207
[PubMed - in process]
3.

Fixation stability and scotoma mapping for patients with low vision.

Elsner AE, Petrig BL, Papay JA, Kollbaum EJ, Clark CA, Muller MS.

Optom Vis Sci. 2013 Feb;90(2):164-73. doi: 10.1097/OPX.0b013e31827cda72.

PMID:
23334309
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Characterizing phenotypes and outcomes of drug-associated liver injury using electronic medical record data.

Shin J, Hunt CM, Suzuki A, Papay JI, Beach KJ, Cheetham TC.

Pharmacoepidemiol Drug Saf. 2013 Feb;22(2):190-8. doi: 10.1002/pds.3388. Epub 2012 Dec 19.

PMID:
23258383
[PubMed - indexed for MEDLINE]
5.

A pre-marketing ALT signal predicts post-marketing liver safety.

Moylan CA, Suzuki A, Papay JI, Yuen NA, Ames M, Hunt CM.

Regul Toxicol Pharmacol. 2012 Aug;63(3):433-9. doi: 10.1016/j.yrtph.2012.05.016. Epub 2012 Jun 2.

PMID:
22668747
[PubMed - indexed for MEDLINE]
6.

Cone photoreceptor packing density and the outer nuclear layer thickness in healthy subjects.

Chui TY, Song H, Clark CA, Papay JA, Burns SA, Elsner AE.

Invest Ophthalmol Vis Sci. 2012 Jun 14;53(7):3545-53. doi: 10.1167/iovs.11-8694.

PMID:
22570340
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Validation of diagnostic accuracy using digital slides in routine histopathology.

Fónyad L, Krenács T, Nagy P, Zalatnai A, Csomor J, Sápi Z, Pápay J, Schönléber J, Diczházi C, Molnár B.

Diagn Pathol. 2012 Mar 31;7:35. doi: 10.1186/1746-1596-7-35.

PMID:
22463804
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Spontaneous adverse event reports of Stevens-Johnson syndrome/toxic epidermal necrolysis: detecting associations with medications.

Papay J, Yuen N, Powell G, Mockenhaupt M, Bogenrieder T.

Pharmacoepidemiol Drug Saf. 2012 Mar;21(3):289-96. doi: 10.1002/pds.2276. Epub 2011 Dec 5.

PMID:
22139991
[PubMed - indexed for MEDLINE]
9.

[Examination of ERCC1 expression in lung cancer patients treated with platinum-based chemotherapy].

Moldvay J, Pápay J, Puskás R, Furák J, Losonczy G, Matolcsy A.

Magy Onkol. 2011 Jun;55(2):105-9. doi: MagyOnkol.2011.55.2.105. Epub 2011 Feb 7. Hungarian.

PMID:
21655476
[PubMed - indexed for MEDLINE]
Free Article
10.

Specific expression of PAD4 and citrullinated proteins in lung cancer is not associated with anti-CCP antibody production.

Baka Z, Barta P, Losonczy G, Krenács T, Pápay J, Szarka E, Sármay G, Babos F, Magyar A, Géher P, Buzás EI, Nagy G.

Int Immunol. 2011 Jun;23(6):405-14. doi: 10.1093/intimm/dxr026. Epub 2011 May 19.

PMID:
21602177
[PubMed - indexed for MEDLINE]
Free Article
11.

The evaluation of drug rechallenge: the casopitant Phase III program.

Hunt CM, Papay JI, Rich DS, Abissi CJ, Russo MW.

Regul Toxicol Pharmacol. 2010 Dec;58(3):539-43. doi: 10.1016/j.yrtph.2010.09.014. Epub 2010 Oct 13.

PMID:
20932869
[PubMed - indexed for MEDLINE]
12.

Response to Letter to the editor by Papay: Regulatory Toxicology and Pharmacology 54 (2009), pp. 84-90. Drug-induced liver injury following positive drug rechallenge.

Papay J.

Regul Toxicol Pharmacol. 2009 Aug;54(3):314. doi: 10.1016/j.yrtph.2009.05.007. Epub 2009 May 19. No abstract available.

PMID:
19460410
[PubMed - indexed for MEDLINE]
13.

Co-medications that modulate liver injury and repair influence clinical outcome of acetaminophen-associated liver injury.

Suzuki A, Yuen N, Walsh J, Papay J, Hunt CM, Diehl AM.

Clin Gastroenterol Hepatol. 2009 Aug;7(8):882-8. doi: 10.1016/j.cgh.2009.03.034. Epub 2009 Apr 9.

PMID:
19362607
[PubMed - indexed for MEDLINE]
14.

Drug-induced liver injury following positive drug rechallenge.

Papay JI, Clines D, Rafi R, Yuen N, Britt SD, Walsh JS, Hunt CM.

Regul Toxicol Pharmacol. 2009 Jun;54(1):84-90. doi: 10.1016/j.yrtph.2009.03.003. Epub 2009 Mar 18.

PMID:
19303041
[PubMed - indexed for MEDLINE]
15.

Platinum-based chemotherapy in lung cancer affects the expression of certain biomarkers including ERCC1.

Pápay J, Sápi Z, Egri G, Gyulai M, Szende B, Losonczy G, Tímár J, Moldvay J.

Pathol Oncol Res. 2009 Sep;15(3):445-50. doi: 10.1007/s12253-009-9155-z. Epub .

PMID:
19253035
[PubMed - indexed for MEDLINE]
16.

Epidermal growth factor receptor (EGFR) high gene copy number and activating mutations in lung adenocarcinomas are not consistently accompanied by positivity for EGFR protein by standard immunohistochemistry.

Pinter F, Papay J, Almasi A, Sapi Z, Szabo E, Kanya M, Tamasi A, Jori B, Varkondi E, Moldvay J, Szondy K, Keri G, Dominici M, Conte P, Eckhardt S, Kopper L, Schwab R, Petak I.

J Mol Diagn. 2008 Mar;10(2):160-8. doi: 10.2353/jmoldx.2008.070125. Epub 2008 Feb 7.

PMID:
18258923
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Monitoring liver safety in drug development: the GSK experience.

Hunt CM, Papay JI, Edwards RI, Theodore D, Alpers DH, Dollery C, Debruin TW, Adkison KK, Stirnadel HA, Gibbs TG.

Regul Toxicol Pharmacol. 2007 Nov;49(2):90-100. Epub 2007 Jun 21.

PMID:
17655994
[PubMed - indexed for MEDLINE]
18.

Immunophenotypic profiling of nonsmall cell lung cancer progression using the tissue microarray approach.

Papay J, Krenacs T, Moldvay J, Stelkovics E, Furak J, Molnar B, Kopper L.

Appl Immunohistochem Mol Morphol. 2007 Mar;15(1):19-30.

PMID:
17536303
[PubMed - indexed for MEDLINE]
19.

[Association of coeliac disease and myasthenia gravis].

Csaplár M, Juhász M, Muzes G, Jakab C, Arányi Z, Rózsa C, Molnár B, Komoly S, Pápay J, Zágoni T, Herszényi L, Tulassay Z.

Orv Hetil. 2006 May 7;147(18):841-4. Hungarian.

PMID:
16784139
[PubMed - indexed for MEDLINE]
20.

[Epidermal growth factor receptor (EGFR): therapeutic target in the treatment of lung adenocarcinoma].

Schwab R, Peták I, Pintér F, Szabó E, Kánya M, Tamási A, Várkondi E, Almási A, Szokolóczi O, Pápay J, Moldvay J, Kéri G, Kopper L.

Orv Hetil. 2005 Nov 13;146(46):2335-42. Review. Hungarian.

PMID:
16370245
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk